Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication

Mostrar otras versiones (1)

New therapeutic targets are a valuable resource for treatment of SARS-CoV-2 viral infection. Genome-wide association studies have identified risk loci associated with COVID-19, but many loci are associated with comorbidities and are not specific to host–virus interactions. Here, we identify and expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Moll, Tobias, Odon, Valerie, Harvey, Calum, Collins, Mark O, Peden, Andrew, Franklin, John, Graves, Emily, Marshall, Jack NG, dos Santos Souza, Cleide, Zhang, Sai, Castelli, Lydia, Hautbergue, Guillaume, Azzouz, Mimoun, Gordon, David, Krogan, Nevan, Ferraiuolo, Laura, Snyder, Michael P, Shaw, Pamela J, Rehwinkel, Jan, Cooper-Knock, Johnathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585911/
https://www.ncbi.nlm.nih.gov/pubmed/36241425
http://dx.doi.org/10.26508/lsa.202201449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585911/
https://www.ncbi.nlm.nih.gov/pubmed/36241425
http://dx.doi.org/10.26508/lsa.202201449

Ejemplares similares